1. Adelaide Research & Scholarship

Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-10 of 12 (Search time: 0.006 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
201117-alpha-hydroxyprogesterone caproate for the prevention of adverse neonatal outcome in multiple pregnancies: A randomized controlled trialLim, A.; Schuit, E.; Bloemenkamp, K.; Bernardus, R.; Duvekot, J.; Erwich, J.; van Eyck, J.; Groenwold, R.; Hasaart, T.; Hummel, P.; Kars, M.; Kwee, A.; van Oirschot, C.; van Pampus, M.; Papatsonis, D.; Porath, M.; Spaanderman, M.; Willekes, C.; Wilpshaar, J.; Mol, B.; et al.
2010Well being of obstetric patients on minimal blood transfusions (WOMB trial)Prick, B.; Steegers, E.; Gerard Jansen, A.; Hop, W.; Essink-Bot, M.; Peters, N.; Uyl-de Groot, C.; Papatsonis, D.; Akerboom, B.; Metz, G.; Bremer, H.; van Loon, A.; Stigter, R.; van der Post, J.; van Alphen, M.; Porath, M.; Rijnders, R.; Spaanderman, M.; Schippers, D.; Bloemenkamp, K.; et al.
2012Remifentanil patient controlled analgesia versus epidural analgesia in labour. A multicentre randomized controlled trialFreeman, L.; Bloemenkamp, K.; Franssen, M.; Papatsonis, D.; Hajenius, P.; van Huizen, M.; Bremer, H.; Van den Akker, E.; Woiski, M.; Porath, M.; van Beek, E.; Schuitemaker, N.; van der Salm, P.; Fong, B.; Radder, C.; Bax, C.; Sikkema, M.; van den Akker-van Marle, M.; van Lith, J.; Lopriore, E.; et al.
2016Nifedipine versus atosiban for threatened preterm birth (APOSTEL III): a multicentre, randomised controlled trialVan Vliet, E.; Nijman, T.; Schuit, E.; Heida, K.; Opmeer, B.; Kok, M.; Gyselaers, W.; Porath, M.; Woiski, M.; Bax, C.; Bloemenkamp, K.; Scheepers, H.; Jacquemyn, Y.; Beek, E.; Duvekot, J.; Franssen, M.; Papatsonis, D.; Kok, J.; Van Der Post, J.; Franx, A.; et al.
2022Hyperemesis gravidarum severity, enteral tube feeding and cardiometabolic markers in offspring cord bloodNijsten, K.; Koot, M.H.; Bais, J.M.; Ris-Stalpers, C.; van Eekelen, R.; Bremer, H.A.; van der Ham, D.P.; Heidema, W.M.; Huisjes, A.; Kleiverda, G.; Kruizenga, H.; Kuppens, S.M.; van Laar, J.O.; Langenveld, J.; van der Made, F.; Papatsonis, D.; Pelinck, M.-J.; Pernet, P.J.; van Rheenen-Flach, L.; Rijnders, R.J.; et al.
2010An economic analysis of induction of labour and expectant monitoring in women with gestational hypertension or pre-eclampsia at term (HYPITAT trial)Vijgen, S.; Koopmans, C.; Opmeer, B.; Groen, H.; Bijlenga, D.; Aarnoudse, J.; Bekedam, D.; van den Berg, P.; de Boer, K.; Burggraaff, J.; Bloemenkamp, K.; Drogtrop, A.; Franx, A.; de Groot, C.; Huisjes, A.; Kwee, A.; van Loon, A.; Lub, A.; Papatsonis, D.; van der Post, J.; et al.
2013Cervical pessaries for prevention of preterm birth in women with a multiple pregnancy (ProTWIN): a multicentre, open-label randomised controlled trialLiem, S.; Schuit, E.; Hegeman, M.; Bais, J.; de Boer, K.; Bloemenkamp, K.; Brons, J.; Duvekot, H.; Nij Bijvanck, B.; Franssen, M.; Gaugler, I.; de Graaf, I.; Oudijk, M.; Papatsonis, D.; Pernet, P.; Porath, M.; Scheepers, L.; Sikkema, M.; Sporken, J.; Visser, H.; et al.
2009Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trialKoopmans, C.; Bijlenga, D.; Groen, H.; Vijgen, S.; Aarnoudse, J.; Bekedam, D.; van den Berg, P.; de Boer, K.; Burggraaff, J.; Bloemenkamp, K.; Drogtrop, A.; Franx, A.; de Groot, C.; Huisjes, A.; Kwee, A.; van Loon, A.; Lub, A.; Papatsonis, D.; van der Post, J.; Roumen, F.; et al.
2012Should cervical favourability play a role in the decision for labour induction in gestational hypertension or mild pre-eclampsia at term? An exploratory analysis of the HYPITAT trialTajik, P.; van der Tuuk, K.; Koopmans, C.; Groen, H.; van Pampus, M.; van der Berg, P.; van der Post, J.; van Loon, A.; de Groot, C.; Kwee, A.; Huisjes, A.; van Beek, E.; Papatsonis, D.; Bloemenkamp, K.; van Unnik, G.; Porath, M.; Rijnders, R.; Stigter, R.; de Boer, K.; Scheepers, L.; et al.
2015Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trialBroekhuijsen, K.; Van Baaren, G.; Van Pampus, M.; Ganzevoort, W.; Sikkema, J.; Woiski, M.; Oudijk, M.; Bloemenkamp, K.; Scheepers, H.; Bremer, H.; Rijnders, R.; Van Loon, A.; Perquin, D.; Sporken, J.; Papatsonis, D.; Van Huizen, M.; Vredevoogd, C.; Brons, J.; Kaplan, M.; Van Kaam, A.; et al.

Discover